[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"current-user-roles":3,"user-subscription":3,"bill:119-hr-1922":4},null,{"bill":5,"indexable":161,"summaries":162,"cosponsors":168,"cosponsorSlugs":179,"actions":182,"amendments":208,"amendmentSponsorSlugs":209,"linkages":210,"sponsorSlug":211},{"statusDate":6,"sponsor":7,"updateDate":16,"cboCostEstimates":17,"originChamber":18,"congress":19,"isByRequest":20,"title":21,"createdAt":22,"committeeReports":23,"cosponsorCount":24,"onBehalfOfSponsor":3,"adminOverride":3,"amendmentCount":25,"actionCount":26,"popularTitle":3,"laws":3,"billType":27,"subjects":28,"introducedDate":6,"committees":29,"congressGovUrl":30,"constitutionalAuthority":31,"policyArea":32,"deletedAt":3,"latestAction":33,"billNumber":35,"cosponsorCountIncludingWithdrawn":24,"status":36,"shortTitle":21,"officialTitle":37,"keyMilestoneCount":24,"updatedAt":38,"policyAreaLower":39,"searchTokens":40,"committeeCodes":160},"2025-03-06",{"firstName":8,"lastName":9,"district":10,"fullName":11,"middleName":12,"state":13,"party":14,"bioguideId":15},"Andrew","Garbarino","2","Rep. Garbarino, Andrew R. [R-NY-2]","R.","NY","R","G000597","2026-02-13T21:03:05Z",[],"House",119,false,"Ensuring Access to Essential Drugs Act","2026-05-11T17:10:57.518Z",[],2,0,4,"hr",[],[],"https:\u002F\u002Fwww.congress.gov\u002Fbill\u002F119th-congress\u002Fhouse-bill\u002F1922","\u003Cpre>\n[Congressional Record Volume 171, Number 43 (Thursday, March 6, 2025)]\n[House]\nFrom the Congressional Record Online through the Government Publishing Office [\u003Ca href=\"https:\u002F\u002Fwww.gpo.gov\">www.gpo.gov\u003C\u002Fa>]\nBy Mr. GARBARINO:\nH.R. 1922.\nCongress has the power to enact this legislation pursuant\nto the following:\nArt. 1, Sec. 8.\n[Page H1039]\n\u003C\u002Fpre>","Health",{"date":6,"text":34},"Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",1922,"in_committee","To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.","2026-05-23T06:45:40.032Z","health",[41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,156,157,158,159],"ensuring","en","ens","ensu","ensur","ensuri","ensurin","access","ac","acc","acce","acces","to","essential","es","ess","esse","essen","essent","essenti","essentia","drugs","dr","dru","drug","act","amend","am","ame","amen","title","ti","tit","titl","xviii","xv","xvi","xvii","of","the","social","so","soc","soci","socia","security","se","sec","secu","secur","securi","securit","exempt","ex","exe","exem","exemp","certain","ce","cer","cert","certa","certai","from","fr","fro","part","pa","par","manufacturer","ma","man","manu","manuf","manufa","manufac","manufact","manufactu","manufactur","manufacture","discount","di","dis","disc","disco","discou","discoun","program","pr","pro","prog","progr","progra","under","un","und","unde","medicare","me","med","medi","medic","medica","medicar","rep","garbarino","ga","gar","garb","garba","garbar","garbari","garbarin","andrew","an","and","andr","andre","ny",[],true,[163],{"versionCode":164,"actionDate":6,"actionDesc":165,"text":166,"updateDate":167},"00","Introduced in House","\u003Cp>\u003Cstrong>Ensuring Access to Essential Drugs Act\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>This bill exempts certain brand-name drugs from the Medicare Part D Manufacturer Discount Program. Under the program, drug manufacturers provide discounts to beneficiaries who have incurred costs above the annual deductible under the Medicare prescription drug benefit.\u003C\u002Fp>\u003Cp>Specifically, the bill exempts from the program orally administered, brand-name drugs that are considered generics for purposes of the Medicaid Drug Rebate Program (per an exception granted by the Centers for Medicare & Medicaid Services).\u003C\u002Fp>","2026-02-13T21:02:02Z",[169,174],{"bioguideId":170,"fullName":171,"party":172,"state":13,"district":173,"sponsorshipDate":6,"isOriginalCosponsor":161,"withdrawn":20,"sponsorshipWithdrawnDate":3},"S001201","Rep. Suozzi, Thomas R. [D-NY-3]","D","3",{"bioguideId":175,"fullName":176,"party":14,"state":177,"district":178,"sponsorshipDate":6,"isOriginalCosponsor":161,"withdrawn":20,"sponsorshipWithdrawnDate":3},"H001086","Rep. Harshbarger, Diana [R-TN-1]","TN","1",{"S001201":180,"H001086":181},"thomas-suozzi","diana-harshbarger",[183,193,199,204],{"actionDate":6,"actionDateTime":3,"text":34,"type":184,"actionCode":185,"sourceSystem":186,"committees":188,"recordedVotes":3,"calendarNumber":3,"sequenceIndex":192,"isKeyMilestone":20},"IntroReferral","H11100",{"code":24,"name":187},"House floor actions",[189],{"name":190,"systemCode":191},"Energy and Commerce Committee","hsif00",1,{"actionDate":6,"actionDateTime":3,"text":34,"type":184,"actionCode":185,"sourceSystem":194,"committees":195,"recordedVotes":3,"calendarNumber":3,"sequenceIndex":25,"isKeyMilestone":20},{"code":24,"name":187},[196],{"name":197,"systemCode":198},"Ways and Means Committee","hswm00",{"actionDate":6,"actionDateTime":3,"text":165,"type":184,"actionCode":200,"sourceSystem":201,"committees":3,"recordedVotes":3,"calendarNumber":3,"sequenceIndex":24,"isKeyMilestone":161},"Intro-H",{"code":202,"name":203},9,"Library of Congress",{"actionDate":6,"actionDateTime":3,"text":165,"type":184,"actionCode":205,"sourceSystem":206,"committees":3,"recordedVotes":3,"calendarNumber":3,"sequenceIndex":207,"isKeyMilestone":161},"1000",{"code":202,"name":203},3,[],{},[],"andrew-r-garbarino"]